Target Healthcare REIT (LON:THRL) Sets New 12-Month High – Should You Buy?

Shares of Target Healthcare REIT (LON:THRL) reached a new 52-week high on Thursday . The stock traded as high as GBX 110.40 and last traded at GBX 108.40, with a volume of 610750 shares traded. The stock had previously closed at GBX 109.

Analysts Set New Price Targets

Separately, Jefferies Financial Group reaffirmed a “hold” rating and set a GBX 101 price objective on shares of Target Healthcare REIT in a research report on Wednesday, May 6th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of GBX 101.

Target Healthcare REIT Stock Up 0.9%

The company’s fifty day moving average is GBX 104.52 and its 200 day moving average is GBX 101.89. The firm has a market cap of £677.30 million, a price-to-earnings ratio of 8.69, a PEG ratio of 1.48 and a beta of 0.69.

Target Healthcare REIT (LON:THRL) last issued its quarterly earnings results on Wednesday, March 18th. The company reported GBX 3.38 EPS for the quarter. Target Healthcare REIT had a return on equity of 10.73% and a net margin of 104.45%. On average, equities research analysts forecast that Target Healthcare REIT will post 6.2219101 EPS for the current fiscal year.

Target Healthcare REIT Company Profile

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.